MyD88 homodimerization inhibitory peptide also led to decreased growth in four different murine mammary carcinomas as well as in the human breast cancer cell line providing evidence that MyD88 is important for growth and metastasis of breast cancer [115]. Here, MYD88 is linked to breast cancer.